6 Results
August/September 2008
- High-Throughput HPLC Purification in Drug Discovery
John J. Isbell, Ph.D.Genomics Institute of theNovartis Research Foundation (GNF)
- Getting Automation to Deliver
Mark Beggs Ph.D.Programme Manager TranslationalMedicine, Wyeth Research
- Translational Medicine Perspectives in Drug Discovery and Development-Part IV: “Surrogate Diseases” Pave the Way for SuccessfulProof-of-Concept Studies Towards Investment Decisions in Large Morbidity and Mortality Outcome Studies in Major Diseases
Giora Z. Feuerstein MDAss. Vice President and Head of Discovery Translational Medicine, Wyeth Research
- Robust Image-Based RNAi Screens for Oncology Drug Target Identification
Steven A. Haney, Ph.D.Genomics Profiling Team LeadPfizer Research
- Pre-Clinical Cardiac Toxicity: Testing Compounds Beyond hERG
Gary Gintant, Ph.D.Senior Group LeaderDept. of Integrative PharmacologyAbbott Laboratories, Inc.
- Gov. Schwarzenegger Celebrates California Innovation and Research at 2008 BIO Conference